Qureight raises $8.5m

The Cambridge-based biotech Qureight uses a proprietary AI platform to help speed up the drug development process by making clinical trials and data analysis more efficient.

Investors also included XTX Ventures, Guinness Ventures, Playfair Capital, Meltwind, Ascension Life Fund and Cambridge Angels.